Linagliptin

Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.

LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes

A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)

A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)

Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus

Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

Efficacy and Safety of Empagliflozin in NODAT

Replication of the CARMELINA Diabetes Trial in Healthcare Claims

Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus

The Effect of LINAGLIPTIN on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects

Linagliptin's Effect on CD34+ Stem Cells

Cognitive Protective Effect of Newer Antidiabetic Drugs

Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose

Effects of DPP4 Inhibition on COVID-19

Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry

Linagliptin and Mesenchymal Stem Cells: A Pilot Study

Effects of Linagliptin on Endothelial Function

The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors

Linagliptin Add-on to Insulin Background Therapy